1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSusan G. Komen: Career Transition Award (CTA) Grant is sponsored by Susan G. Komen Breast Cancer Foundation Inc. Supports postdoctoral and clinical fellows in launching independent breast cancer research careers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Susan G. Komen Career Transition Awards (CTA) & Career Catalyst Research (CCR) Grants – 2026 | Office of Research Susan G. Komen Career Transition Awards (CTA) & Career Catalyst Research (CCR) Grants – 2026 URL: https://www.
komen. org/breast-cancer-research/grants/opportunities/ NOTE: The foundation has not yet announced the 2026 cycle for this LSO but is expected to soon. The internal competition is announced in anticipation to allow prospective applicants sufficient time to prepare their materials.
All information in this announcement is subject to change. The Susan G. Komen (SGK) Career Transition Awards (CTA) and Career Catalyst Research (CCR) grants are intended to support cutting-edge breast cancer research that will provide the greatest benefit to patients.
SGK focuses on conquering metastatic and aggressive breast cancers, advancing personalized breast care and eliminating breast cancer disparities and inequities. Research projects must be hypothesis-driven, breast cancer-focused studies. They may be considered basic, translational, clinical and/or population science in nature and should align with SGK’s mission to save lives.
Career Transition Awards (CTA) aims to help outstanding senior postdoctoral and clinical research fellows launch their competitive, independent breast cancer research careers. Career Catalyst Research (CCR) grants foster promising breast cancer researchers who are in the early stages of their faculty careers who will emerge as the next key leaders in the fight against breast cancer.
SGK seeks to support investigators with “protected time” for research career development under the guidance of a Mentor Committee. Up to $650,000 over up to 5 years over two phases of the Award as follows: Phase 1 : Up to $100,000 per year (direct costs only) for up to 2 years may be requested to support the final years of postdoctoral work.
Phase 2 : Up to $150,000 per year (direct and indirect costs) for up to 3 years to support for independent research as tenure-track investigators. Up to $150,000 per year for up to 3 years ($450,000 total) in combined direct and indirect costs. Be pursuing independent breast cancer research careers.
Be in the final years of mentored postdoctoral research training positions. Clinical fellows are considered eligible and equal to the postdoctoral rank.
Have no more than five years of total postdoctoral research experience at the time of Letter of Intent submission (July 24, 2026 **Anticipated) Currently hold a full-time faculty appointment or have a formal offer letter from the Institution that confirms position and start date by the Application due date (October 2, 2026 **Anticipated).
NOT have held any faculty appointment, including non-tenure and tenure track appointments combined, for more than a total of 6 years by the Application due date (October 2, 2026 **Anticipated). NOT currently be or have been a Principal Investigator on an existing NIH R01 grant or their equivalent as of the date of Award Notification (on or around April 15, 2027 **Anticipated).
Internal Selection Process The internal selection process depends on whether your grants are managed by BU or Boston Medical Center (BMC). Use the steps below to determine this information: Step 1: Open the BUMC Home Institution Finder Step 3: Follow one process : If you see BU or BU-CAMED, follow BU Process below If you see BMC, follow the BMC Process below BU may forward 1 nominee for each award .
Interested applicants should submit the following materials via InfoReady Review by: 6/1/2026 2-page Research Plan providing clear and concise statement of the research question, hypothesis, specific aims of the project throughout the grant term, and how the project would increase understanding of breast cancer and lead to advances in the field. References may be included on one additional page.
List of pending and current other support – can be in NIH format Up-to-date Biosketch or CV As necessary, a faculty review committee will review internal applications and select the institutional nominee(s). BMC may forward 1 nominee for each award .
If you are a BUMC faculty member who works in BMC space or you are a fellow whose faculty advisor is a BMC investigator, please contact the Program Manager of Strategic Research Growth, Carolina Giudice ( carolina. giudice@bmc. org ) by Friday, May 22 to express interest in this opportunity.
In your email, please indicate which grant you wish to apply to (CTA or CCR). BMC Deadline to Express Interest: Friday, May 22, 2026 BU Internal Materials Due: Monday, June 1, 2026 by 11:59 pm ET Anticipated Notification Date: Monday, June 22, 2026 **Anticipated External Materials Due: Friday, July 24, 2026
According to the current listing, eligibility includes: Postdoctoral fellows and clinical fellows working under the guidance of a mentor in breast cancer research. Confirm the full requirements in the official notice before applying.
The current listing shows up to $650,000 over five years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Susan G. Komen: Career Transition Award (CTA) Grant is funded by Susan G. Komen Breast Cancer Foundation Inc. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleOMB's overhaul of the Uniform Guidance drew nearly 500,000 public comments — 94% opposed in one analysis — and now has Senate Appropriations Chair Susan Collins warning it will harm rural communities and biomedical research. With an October 1, 2026 effective date and litigation likely, here is what the political fight means for grant recipients and how to plan for outcomes you cannot control.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read article